U-Chart Analysis:D.Western Therapeutics Institute, Inc.:4576

※The values of financial statements might be different from the actual ones. Please confirm the original. [instructions]

Main FunctionHelp Company NameHelp CodeHelp Types of IndustryHelp Market Name Fiscal Year End Year of Listing
Browse U-Chart Add to 'Companies Comparison' list Compare Lustrum Ullet index D.Western Therapeutics Institute, Inc. Go to web site 4576 Medicals 東証グロース December 1, 2000 2009.
Analysis u.gifU-Chart AnalysisHelp hikaku.gifAdd to 'Companies Comparison' listHelp u2.gifCompare LustrumHelp mark.gifUllet indexHelp
Accounts Information Balance Sheet Profit and Loss Account Cash Flow Statement
Display

D.Western Therapeutics Institute, Inc. Balance Sheet(B/S)

[Show - Hide] U-Chart:Balance Sheet (B/S)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

D.Western Therapeutics Institute, Inc. Balance Sheet 2023年12月期 D.Western Therapeutics Institute, Inc. Balance Sheet 2022年12月期 D.Western Therapeutics Institute, Inc. Balance Sheet 2021年12月期 D.Western Therapeutics Institute, Inc. Balance Sheet 2020年12月期 D.Western Therapeutics Institute, Inc. Balance Sheet 2019年12月期

[Show - Hide] Balance Sheet (B/S)Help  ※Unit:Millions of Yen

Accounting Date December 31, 2023 December 31, 2022 December 31, 2021 December 31, 2020 December 31, 2019
Cash and Cash Equivalents 1,867 2,335 1,934 2,308 1,541
Other Current AssetsHelp 271 324 228 195 175
Tangible Fixed AssetsHelp 10 10 5 5 3
Intangible Fixed AssetHelp 87 125 167 208 250
Investments and OthersHelp 139 163 129 21 13
Total AssetsHelp 2,373 2,956 2,463 2,738 1,981
Total Current LiabilitiesHelp 218 251 245 234 228
Total Long-term LiabilitiesHelp 876 848 210 340 360
Shareholder's EquityHelp 1,280 1,857 2,007 2,164 1,393
Total LiabilitiesHelp 2,373 2,956 2,463 2,738 1,981

D.Western Therapeutics Institute, Inc. Profit and Loss Account(P/L)

[表示非表示] U-Chart:Profit and Loss Account (P/L)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

D.Western Therapeutics Institute, Inc. Profit and Loss Account 2023年12月期 D.Western Therapeutics Institute, Inc. Profit and Loss Account 2022年12月期 D.Western Therapeutics Institute, Inc. Profit and Loss Account 2021年12月期 D.Western Therapeutics Institute, Inc. Profit and Loss Account 2020年12月期 D.Western Therapeutics Institute, Inc. Profit and Loss Account 2019年12月期

[Show - Hide] Profit and Loss Account (P/L)Help  ※Unit:Millions of Yen

Accounting Date December 31, 2023 December 31, 2022 December 31, 2021 December 31, 2020 December 31, 2019
Amount of Sales 428 448 414 356 581
Total Sales 428 448 414 356 581
Cost of SalesHelp 37 28 20 17 26
Other Costs and RevenueHelp 1,204 850 543 615 421
Total CostsHelp 1,241 878 563 632 447
Net RevenueHelp 392 421 394 339 555
Earnings Before TaxHelp -827 -440 -160 -290 110
Net IncomeHelp -812 -430 -149 -276 133
Net Income -812 -430 -149 -276 133

D.Western Therapeutics Institute, Inc. Cash Flow Statement(C/F)

[表示非表示] U-Chart:Cash Flow Statement (C/F)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

D.Western Therapeutics Institute, Inc. Cash Flow Statement 2023年12月期 D.Western Therapeutics Institute, Inc. Cash Flow Statement 2022年12月期 D.Western Therapeutics Institute, Inc. Cash Flow Statement 2021年12月期 D.Western Therapeutics Institute, Inc. Cash Flow Statement 2020年12月期 D.Western Therapeutics Institute, Inc. Cash Flow Statement 2019年12月期

[Show - Hide] Cash Flow Statement (C/F)Help  ※Unit:Millions of Yen

Accounting Date December 31, 2023 December 31, 2022 December 31, 2021 December 31, 2020 December 31, 2019
Operating Cash Flow(OFC)Help -587 -355 -176 -216 176
Investing Cash Flow(ICF)Help -15 -140 -111 -13 -100
Financing Cash FlowHelp 134 867 -104 1,004 1,004
Exchange Difference of Cash and Cash EquivalentsHelp 0 28 17 -7 -1,123
Net Increase and Decrease in Cash and Cash Equivalentsn -467 401 -374 767 -43

他社比較Help

Companies in 'Companies Comparison' list

Browsing historyHelp

Your reecently viewed companies

D.Western Therapeutics Institute, Inc.

Company where related level is highHelp

SymBio Pharmaceuticals Limited
TOWA PHARMACEUTICAL CO.,LTD.
Mitsubishi Tanabe Pharma Corporation
ASKA Pharmaceutical Co.,Ltd.
DAIICHI SANKYO COMPANY, LIMITED
Perseus Proteomics Inc.
GNI Group Ltd.
Tsubota Laboratory Incorporated
MUROMACHI CHEMICALS INC.
KYORIN Pharmaceutical Co., Ltd.